Independent Negative Prognostic Role of TCF1 Expression within the Wnt/β-Catenin Signaling Pathway in Primary Breast Cancer Patients

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma

(2018) Concetta Saponaro et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy

(2018) Concetta Saponaro et al.   ONCOGENE

NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings

(2018) Matteo Centonze et al.   Translational Oncology

NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression

(2018) Qiqi Wang et al.   Cell Death & Disease

LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers

(2018) Sylvie Maubant et al.   Oncotarget

Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis

(2018) Alexandre Vallée et al.   Frontiers in Immunology

Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists

(2018) Ping Yin et al.   CANCER SCIENCE

Phosphorylation of NHERF1 S279 and S301 differentially regulates breast cancer cell phenotype and metastatic organotropism

(2018) Maria Raffaella Greco et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients

(2017) Anita Mangia et al.   Oncotarget

β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients

(2016) Laura Schirosi et al.   Oncotarget

NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway–Driven Intestinal Neoplasia

(2016) Maria-Magdalena Georgescu et al.   NEOPLASIA

Prognostic Value of β-catenin Expression in Breast Cancer Patients: a Meta-analysis

(2015) De-Pu Zhang et al.   Asian Pacific Journal of Cancer Prevention

The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy

(2015) Anita Mangia et al.   CANCER BIOLOGY & THERAPY

High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression

(2013) Andrea Malfettone et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Nuclear NHERF1 expression as a prognostic marker in breast cancer

(2013) A Paradiso et al.   Cell Death & Disease

Prognostic Significance of cyclin D1, β-catenin, and MTA1 in Patients with Invasive Ductal Carcinoma of the Breast

(2012) Chun-Wen Cheng et al.   ANNALS OF SURGICAL ONCOLOGY

Overexpression of nuclear NHERF1 in advanced colorectal cancer: Association with hypoxic microenvironment and tumor invasive phenotype

(2012) Andrea Malfettone et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Frizzled and LRP5/6 Receptors for Wnt/ -Catenin Signaling

(2012) B. T. MacDonald et al.   Cold Spring Harbor Perspectives in Biology

Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance

(2011) Thomas Karn et al.   BREAST CANCER RESEARCH AND TREATMENT

Human epidermal growth factor receptor 2, Na+/H+ exchanger regulatory factor 1, and breast cancer susceptibility gene-1 as new biomarkers for familial breast cancers

(2011) Annita Mangia et al.   HUMAN PATHOLOGY

Cytoplasmic Localization of  -Catenin is a Marker of Poor Outcome in Breast Cancer Patients

(2010) E. Lopez-Knowles et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling

(2010) D S Wheeler et al.   ONCOGENE

LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy

(2010) C.-C. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inverse correlation of the up-regulation of FZD10 expression and the activation of β-catenin in synchronous colorectal tumors

(2009) Satoshi Nagayama et al.   CANCER SCIENCE

Biological role of NHERF1 protein expression in breast cancer

(2009) Anita Mangia et al.   HISTOPATHOLOGY

Roles of NHERF1/EBP50 in Cancer

(2008) Maria-Magdalena Georgescu et al.   CURRENT MOLECULAR MEDICINE